;PMID: 10975709
;source_file_732.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..30] = [t:0..30]
;1)sentence:[e:35..173] = [t:35..173]
;2)section:[e:177..239] = [t:177..239]
;3)section:[e:243..383] = [t:243..383]
;4)sentence:[e:387..503] = [t:387..503]
;5)sentence:[e:504..769] = [t:504..769]
;6)sentence:[e:771..940] = [t:771..940]
;7)sentence:[e:941..1269] = [t:941..1269]
;8)sentence:[e:1270..1379] = [t:1270..1379]
;9)sentence:[e:1380..1511] = [t:1380..1511]
;10)sentence:[e:1512..1699] = [t:1512..1699]
;11)sentence:[e:1700..1758] = [t:1700..1758]
;12)section:[e:1762..1807] = [t:1762..1807]

;section 0 Span:0..30
;Pancreas  2000 Aug;21(2):152-7
(SEC
  (FRAG (IN:[0..8] Pancreas) (CD:[10..14] 2000) (.:[15..22] Aug;21-LRB-)
        (CD:[22..23] 2) (-RRB-:[23..24] -RRB-) (CD:[24..28] :152) (::[28..29] -)
        (CD:[29..30] 7)))

;sentence 1 Span:35..173
;Reassessment of K-ras mutations at codon 12 by direct PCR and sequencing from
; tissue microdissection in human pancreatic adenocarcinomas.
;[51..56]:gene-rna:"K-ras"
;[57..66]:variation-event:"mutations"
;[70..78]:variation-location:"codon 12"
;[146..172]:malignancy:"pancreatic adenocarcinomas"
(SENT
  (NP-HLN
    (NP (NN:[35..47] Reassessment))
    (PP (IN:[48..50] of)
      (NP
        (NP (NN:[51..56] K-ras) (NNS:[57..66] mutations))
        (PP-LOC (IN:[67..69] at)
          (NP (NN:[70..75] codon) (CD:[76..78] 12)))))
    (PP (IN:[79..81] by)
      (NP
        (NP (JJ:[82..88] direct) (NN:[89..92] PCR))
        (CC:[93..96] and)
        (NP
          (NP (NN:[97..107] sequencing))
          (PP (IN:[108..112] from)
            (NP (NN:[114..120] tissue) (NN:[121..136] microdissection))))))
    (PP-LOC (IN:[137..139] in)
      (NP (JJ:[140..145] human)
         (JJ:[146..156] pancreatic) (NNS:[157..172] adenocarcinomas)))
    (.:[172..173] .)))

;section 2 Span:177..239
;Aoki Y, Hosaka S, Tachibana N, Karasawa Y, Kawa S, Kiyosawa K.
(SEC
  (FRAG (NNP:[177..181] Aoki) (NNP:[182..183] Y) (,:[183..184] ,)
        (NNP:[185..191] Hosaka) (NNP:[192..194] S,) (NNP:[195..204] Tachibana)
        (NNP:[205..206] N) (,:[206..207] ,) (NNP:[208..216] Karasawa)
        (NNP:[217..218] Y) (,:[218..219] ,) (NNP:[220..224] Kawa)
        (NNP:[225..227] S,) (NNP:[228..236] Kiyosawa) (NNP:[237..239] K.)))

;section 3 Span:243..383
;The Second Department of Internal Medicine, Shinshu University School of 
;Medicine, Matsumoto, Nagono, Japan. yaoki55@hsp.md.shinshu-u.ac.jp
(SEC
  (FRAG (DT:[243..246] The) (JJ:[247..253] Second) (NNP:[254..264] Department)
        (IN:[265..267] of) (NNP:[268..276] Internal) (NNP:[277..285] Medicine)
        (,:[285..286] ,) (NNP:[287..294] Shinshu) (NNP:[295..305] University)
        (NNP:[306..312] School) (IN:[313..315] of) (NNP:[317..325] Medicine)
        (,:[325..326] ,) (NNP:[327..336] Matsumoto) (,:[336..337] ,)
        (NNP:[338..344] Nagono) (,:[344..345] ,) (NNP:[346..351] Japan)
        (.:[351..352] .) (``:[353..367] yaoki55@hsp.md) (NN:[367..375] .shinshu)
        (::[375..376] -) (NN:[376..381] u.ac.) (.:[381..383] jp)))

;sentence 4 Span:387..503
;K-ras mutations at codon 12 have been detected in almost all pancreatic 
;adenocarcinomas by highly sensitive assays.
;[387..392]:gene-rna:"K-ras"
;[393..402]:variation-event:"mutations"
;[406..414]:variation-location:"codon 12"
;[448..475]:malignancy:"pancreatic  adenocarcinomas"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[387..392] K-ras) (NNS:[393..402] mutations))
      (PP-LOC (IN:[403..405] at)
        (NP (NN:[406..411] codon) (CD:[412..414] 12))))
    (VP (VBP:[415..419] have)
      (VP (VBN:[420..424] been)
        (VP (VBN:[425..433] detected)
          (NP-1 (-NONE-:[433..433] *))
          (PP-LOC (IN:[434..436] in)
            (NP (RB:[437..443] almost) (DT:[444..447] all)
               (JJ:[448..458] pancreatic) (NNS:[460..475] adenocarcinomas)))
          (PP-MNR (IN:[476..478] by)
            (NP
              (ADJP (RB:[479..485] highly) (JJ:[486..495] sensitive))
              (NNS:[496..502] assays))))))
    (.:[502..503] .)))

;sentence 5 Span:504..769
;We reassessed the K-ras mutation  status by direct polymerase chain reaction
;(PCR) and sequencing from tissue  microdissection without DNA extraction in
;10 pancreatic adenocarcinomas, and  also assessed the K-ras and DPC4 genes in
;nine pancreatic cancer cell lines.
;[522..527]:gene-rna:"K-ras"
;[555..565]:gene-protein:"polymerase"
;[660..686]:malignancy:"pancreatic adenocarcinomas"
;[711..716]:gene-rna:"K-ras"
;[721..725]:gene-rna:"DPC4"
;[740..768]:malignancy:"pancreatic cancer cell lines"
(SENT
  (S
    (NP-SBJ (PRP:[504..506] We))
    (VP
      (VP (VBD:[507..517] reassessed)
        (NP (DT:[518..521] the) (NN:[522..527] K-ras) (NN:[528..536] mutation)
            (NN:[538..544] status))
        (PP-MNR (IN:[545..547] by)
          (NP
            (NP (JJ:[548..554] direct)
              (NML
                (NML (NN:[555..565] polymerase) (NN:[566..571] chain)
                     (NN:[572..580] reaction))
                (NML (-LRB-:[581..582] -LRB-) (NN:[582..585] PCR)
                     (-RRB-:[585..586] -RRB-))))
            (CC:[587..590] and)
            (NP
              (NP (NN:[591..601] sequencing))
              (PP (IN:[602..606] from)
                (NP
                  (NP (NN:[607..613] tissue) (NN:[615..630] microdissection))
                  (PP (IN:[631..638] without)
                    (NP (NN:[639..642] DNA) (NN:[643..653] extraction))))))))
        (PP (IN:[654..656] in)
          (NP (CD:[657..659] 10)
             (JJ:[660..670] pancreatic) (NNS:[671..686] adenocarcinomas))))
      (,:[686..687] ,) (CC:[688..691] and)
      (VP
        (ADVP (RB:[693..697] also))
        (VBD:[698..706] assessed)
        (NP (DT:[707..710] the)
          (NML
            (NML (NN:[711..716] K-ras)
              (NML-1 (-NONE-:[716..716] *P*)))
            (CC:[717..720] and)
            (NML (NN:[721..725] DPC4)
              (NML-1 (NNS:[726..731] genes)))))
        (PP (IN:[732..734] in)
          (NP (CD:[735..739] nine)
             (JJ:[740..750] pancreatic) (NN:[751..757] cancer)
             (NN:[758..762] cell) (NNS:[763..768] lines)))))
    (.:[768..769] .)))

;sentence 6 Span:771..940
;Eight pancreatic adenocarcinomas were found to harbor K-ras mutations at
;codon  12 of either GTT or GAT, five of which were inferred to harbor
;amplified mutant  alleles.
;[777..803]:malignancy:"pancreatic adenocarcinomas"
;[825..830]:gene-rna:"K-ras"
;[831..840]:variation-event:"mutations"
;[844..853]:variation-location:"codon  12"
;[864..867]:variation-state-original:"GTT"
;[871..874]:variation-state-original:"GAT"
(SENT
  (S
    (NP-SBJ-2
      (NP (CD:[771..776] Eight)
         (JJ:[777..787] pancreatic) (NNS:[788..803] adenocarcinomas))
      (SBAR-3 (-NONE-:[803..803] *ICH*)))
    (VP (VBD:[804..808] were)
      (VP (VBN:[809..814] found)
        (S
          (NP-SBJ-2 (-NONE-:[814..814] *))
          (VP (TO:[815..817] to)
            (VP (VB:[818..824] harbor)
              (NP (NN:[825..830] K-ras) (NNS:[831..840] mutations))
              (PP-LOC (IN:[841..843] at)
                (NP
                  (NP (NN:[844..849] codon) (CD:[851..853] 12))
                  (PP (IN:[854..856] of)
                    (NP (CC:[857..863] either) (NN:[864..867] GTT)
                        (CC:[868..870] or) (NN:[871..874] GAT)))))
              (,:[874..875] ,)
              (SBAR-3
                (WHNP-1
                  (NP (CD:[876..880] five))
                  (WHPP (IN:[881..883] of)
                    (WHNP (WDT:[884..889] which))))
                (S
                  (NP-SBJ-1 (-NONE-:[889..889] *T*))
                  (VP (VBD:[890..894] were)
                    (VP (VBN:[895..903] inferred)
                      (S
                        (NP-SBJ-1 (-NONE-:[903..903] *))
                        (VP (TO:[904..906] to)
                          (VP (VB:[907..913] harbor)
                            (NP (VBN:[914..923] amplified)
                                (JJ:[924..930] mutant) (NNS:[932..939] alleles))))))))))))))
    (.:[939..940] .)))

;sentence 7 Span:941..1269
;Mutations at the sites other than codon 12 were found in seven of 70  clones
;(seven of 9,380 bases) by the TA cloning analysis, suggesting that 
;artifactual mutations at the first or second base of codon 12 before and
;during  PCR could occur at a frequency of approximately 10(-3), enough for
;highly  sensitive assays to detect.
;[941..950]:variation-event:"Mutations"
;[975..983]:variation-location:"codon 12"
;[1098..1107]:variation-event:"mutations"
;[1115..1120]...[1131..1147]:variation-location:"first"..."base of codon 12"
;[1124..1147]:variation-location:"second base of codon 12"
(SENT
  (S
    (NP-SBJ-3
      (NP (NNS:[941..950] Mutations))
      (PP (IN:[951..953] at)
        (NP
          (NP (DT:[954..957] the) (NNS:[958..963] sites))
          (ADJP (JJ:[964..969] other)
            (PP (IN:[970..974] than)
              (NP (NN:[975..980] codon) (CD:[981..983] 12)))))))
    (VP (VBD:[984..988] were)
      (VP (VBN:[989..994] found)
        (NP-3 (-NONE-:[994..994] *))
        (PP-LOC (IN:[995..997] in)
          (NP
            (NP (CD:[998..1003] seven))
            (PP (IN:[1004..1006] of)
              (NP (CD:[1007..1009] 70) (NNS:[1011..1017] clones)
                (PRN (-LRB-:[1018..1019] -LRB-)
                  (NP
                    (NP (CD:[1019..1024] seven))
                    (PP (IN:[1025..1027] of)
                      (NP (CD:[1028..1033] 9,380) (NNS:[1034..1039] bases))))
                  (-RRB-:[1039..1040] -RRB-))))))
        (PP-MNR (IN:[1041..1043] by)
          (NP (DT:[1044..1047] the) (NN:[1048..1050] TA)
              (NN:[1051..1058] cloning) (NN:[1059..1067] analysis)))
        (,:[1067..1068] ,)
        (S-ADV
          (NP-SBJ (-NONE-:[1068..1068] *))
          (VP (VBG:[1069..1079] suggesting)
            (SBAR (IN:[1080..1084] that)
              (S
                (NP-SBJ
                  (NP (JJ:[1086..1097] artifactual) (NNS:[1098..1107] mutations))
                  (PP-LOC (IN:[1108..1110] at)
                    (NP
                      (NP (DT:[1111..1114] the)
                        (NML
                          (NML (JJ:[1115..1120] first)
                            (NML-2 (-NONE-:[1120..1120] *P*)))
                          (CC:[1121..1123] or)
                          (NML (JJ:[1124..1130] second)
                            (NML-2 (NN:[1131..1135] base)))))
                      (PP (IN:[1136..1138] of)
                        (NP (NN:[1139..1144] codon) (CD:[1145..1147] 12))))))
                (PP-TMP (IN:[1148..1154] before) (CC:[1155..1158] and)
                        (IN:[1159..1165] during)
                  (NP (NN:[1167..1170] PCR)))
                (VP (MD:[1171..1176] could)
                  (VP (VB:[1177..1182] occur)
                    (PP (IN:[1183..1185] at)
                      (NP
                        (NP
                          (NP (DT:[1186..1187] a) (NN:[1188..1197] frequency))
                          (PP (IN:[1198..1200] of)
                            (NP (RB:[1201..1214] approximately)
                                (CD:[1215..1221] 10-LRB--3-RRB-))))
                        (,:[1221..1222] ,)
                        (ADJP (RB:[1223..1229] enough)
                          (SBAR
                            (WHNP-1 (IN:[1230..1233] for))
                            (S
                              (NP-SBJ (RB:[1234..1240] highly)
                                      (JJ:[1242..1251] sensitive)
                                      (NNS:[1252..1258] assays))
                              (VP (TO:[1259..1261] to)
                                (VP (VB:[1262..1268] detect)
                                  (NP-1 (-NONE-:[1268..1268] *T*)))))))))))))))))
    (.:[1268..1269] .)))

;sentence 8 Span:1270..1379
;Two cell lines without K-ras mutations at codon 12  were found to have
;homozygous deletions at the DPC4 gene.
;[1274..1284]:malignancy:"cell lines"
;[1293..1298]:gene-rna:"K-ras"
;[1299..1308]:variation-event:"mutations"
;[1312..1320]:variation-location:"codon 12"
;[1341..1361]:variation-type:"homozygous deletions"
;[1369..1373]:gene-rna:"DPC4"
(SENT
  (S
    (NP-SBJ-1
      (NP (CD:[1270..1273] Two)
         (NN:[1274..1278] cell) (NNS:[1279..1284] lines))
      (PP (IN:[1285..1292] without)
        (NP
          (NP (NN:[1293..1298] K-ras) (NNS:[1299..1308] mutations))
          (PP-LOC (IN:[1309..1311] at)
            (NP (NN:[1312..1317] codon) (CD:[1318..1320] 12))))))
    (VP (VBD:[1322..1326] were)
      (VP (VBN:[1327..1332] found)
        (S
          (NP-SBJ-1 (-NONE-:[1332..1332] *))
          (VP (TO:[1333..1335] to)
            (VP (VB:[1336..1340] have)
              (NP (JJ:[1341..1351] homozygous) (NNS:[1352..1361] deletions))
              (PP-LOC (IN:[1362..1364] at)
                (NP (DT:[1365..1368] the) (NN:[1369..1373] DPC4)
                    (NN:[1374..1378] gene))))))))
    (.:[1378..1379] .)))

;sentence 9 Span:1380..1511
;Thus the K-ras  mutation status was demonstrated to be correctly determined
;by just direct  sequencing from tissue microdissection.
;[1389..1394]:gene-rna:"K-ras"
;[1396..1404]:variation-event:"mutation"
(SENT
  (S
    (ADVP (RB:[1380..1384] Thus))
    (NP-SBJ-1 (DT:[1385..1388] the) (NN:[1389..1394] K-ras)
              (NN:[1396..1404] mutation) (NN:[1405..1411] status))
    (VP (VBD:[1412..1415] was)
      (VP (VBN:[1416..1428] demonstrated)
        (S
          (NP-SBJ-1 (-NONE-:[1428..1428] *))
          (VP (TO:[1429..1431] to)
            (VP (VB:[1432..1434] be)
              (ADVP (RB:[1435..1444] correctly))
              (VP (VBN:[1445..1455] determined)
                (NP-1 (-NONE-:[1455..1455] *))
                (PP (IN:[1456..1458] by)
                  (NP
                    (NP (RB:[1459..1463] just) (JJ:[1464..1470] direct)
                        (NN:[1472..1482] sequencing))
                    (PP (IN:[1483..1487] from)
                      (NP (NN:[1488..1494] tissue)
                          (NN:[1495..1510] microdissection)))))))))))
    (.:[1510..1511] .)))

;sentence 10 Span:1512..1699
;All possible mutations or multiple  mutations at K-ras codon 12 that have
;been reported in pancreatic  adenocarcinomas might include artifacts or
;mutations without a selective  advantage.
;[1525..1534]:variation-event:"mutations"
;[1548..1557]:variation-event:"mutations"
;[1561..1566]:gene-rna:"K-ras"
;[1567..1575]:variation-location:"codon 12"
;[1603..1630]:malignancy:"pancreatic  adenocarcinomas"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (DT:[1512..1515] All)
          (NML
            (NML (JJ:[1516..1524] possible) (NNS:[1525..1534] mutations))
            (CC:[1535..1537] or)
            (NML (JJ:[1538..1546] multiple) (NNS:[1548..1557] mutations))))
        (PP-LOC (IN:[1558..1560] at)
          (NP (NN:[1561..1566] K-ras)
             (NN:[1567..1572] codon) (CD:[1573..1575] 12))))
      (SBAR
        (WHNP-1 (WDT:[1576..1580] that))
        (S
          (NP-SBJ-1 (-NONE-:[1580..1580] *T*))
          (VP (VBP:[1581..1585] have)
            (VP (VBN:[1586..1590] been)
              (VP (VBN:[1591..1599] reported)
                (NP-1 (-NONE-:[1599..1599] *))
                (PP-LOC (IN:[1600..1602] in)
                  (NP (JJ:[1603..1613] pancreatic)
                      (NNS:[1615..1630] adenocarcinomas)))))))))
    (VP (MD:[1631..1636] might)
      (VP (VB:[1637..1644] include)
        (NP
          (NP (NNS:[1645..1654] artifacts) (CC:[1655..1657] or)
              (NNS:[1658..1667] mutations))
          (PP (IN:[1668..1675] without)
            (NP (DT:[1676..1677] a) (JJ:[1678..1687] selective)
                (NN:[1689..1698] advantage))))))
    (.:[1698..1699] .)))

;sentence 11 Span:1700..1758
;In addition, we must be very cautious about contamination.
(SENT
  (S
    (PP (IN:[1700..1702] In)
      (NP (NN:[1703..1711] addition)))
    (,:[1711..1712] ,)
    (NP-SBJ (PRP:[1713..1715] we))
    (VP (MD:[1716..1720] must)
      (VP (VB:[1721..1723] be)
        (ADJP-PRD (RB:[1724..1728] very) (JJ:[1729..1737] cautious)
          (PP (IN:[1738..1743] about)
            (NP (NN:[1744..1757] contamination))))))
    (.:[1757..1758] .)))

;section 12 Span:1762..1807
;PMID: 10975709 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1762..1766] PMID) (::[1766..1767] :) (CD:[1768..1776] 10975709)
        (NN:[1777..1778] -LSB-) (NNP:[1778..1784] PubMed) (::[1785..1786] -)
        (NN:[1787..1794] indexed) (IN:[1795..1798] for)
        (NNP:[1799..1807] MEDLINE-RSB-)))
